These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25372757)

  • 21. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
    Bulawa CE; Connelly S; Devit M; Wang L; Weigel C; Fleming JA; Packman J; Powers ET; Wiseman RL; Foss TR; Wilson IA; Kelly JW; Labaudinière R
    Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9629-34. PubMed ID: 22645360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition.
    Julius RL; Hawthorne MF
    Drug News Perspect; 2008 Jun; 21(5):258-66. PubMed ID: 18596990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.
    Zhao L; Buxbaum JN; Reixach N
    Biochemistry; 2013 Mar; 52(11):1913-26. PubMed ID: 23414091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils.
    Redondo C; Damas AM; Olofsson A; Lundgren E; Saraiva MJ
    J Mol Biol; 2000 Dec; 304(3):461-70. PubMed ID: 11090287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic stabilization of an oligomeric protein by a single ligand binding event.
    Wiseman RL; Johnson SM; Kelker MS; Foss T; Wilson IA; Kelly JW
    J Am Chem Soc; 2005 Apr; 127(15):5540-51. PubMed ID: 15826192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci.
    Mu Y; Jin S; Shen J; Sugano A; Takaoka Y; Qiang L; Imbimbo BP; Yamamura K; Li Z
    FEBS Lett; 2015 Mar; 589(7):849-56. PubMed ID: 25728271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved water mediated H-bonding dynamics of Ser117 and Thr119 residues in human transthyretin-thyroxin complexation: inhibitor modeling study through docking and molecular dynamics simulation.
    Banerjee A; Bairagya HR; Mukhopadhyay BP; Nandi TK; Mishra DK
    J Mol Graph Model; 2013 Jul; 44():70-80. PubMed ID: 23732306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Non-amyloidogenic G101S Transthyretin.
    Wakita Y; Sato T; Chosa K; Suico MA; Sasaki R; Kawano S; Hashimoto N; Teranishi Y; Imai Y; Morioka H; Shuto T; Kai H
    Biol Pharm Bull; 2018; 41(4):628-636. PubMed ID: 29607936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid.
    Kelly JW; Colon W; Lai Z; Lashuel HA; McCulloch J; McCutchen SL; Miroy GJ; Peterson SA
    Adv Protein Chem; 1997; 50():161-81. PubMed ID: 9338081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
    Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.
    Choi S; Reixach N; Connelly S; Johnson SM; Wilson IA; Kelly JW
    J Am Chem Soc; 2010 Feb; 132(4):1359-70. PubMed ID: 20043671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.
    Sörgjerd K; Klingstedt T; Lindgren M; Kågedal K; Hammarström P
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1072-8. PubMed ID: 18983977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the effect of mutations and ligand binding on transthyretin homotetramer dynamics.
    Saldaño TE; Zanotti G; Parisi G; Fernandez-Alberti S
    PLoS One; 2017; 12(7):e0181019. PubMed ID: 28704493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors.
    Zanotti G; Cendron L; Folli C; Florio P; Imbimbo BP; Berni R
    FEBS Lett; 2013 Aug; 587(15):2325-31. PubMed ID: 23792159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
    J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
    Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
    Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis.
    Mangione PP; Porcari R; Gillmore JD; Pucci P; Monti M; Porcari M; Giorgetti S; Marchese L; Raimondi S; Serpell LC; Chen W; Relini A; Marcoux J; Clatworthy IR; Taylor GW; Tennent GA; Robinson CV; Hawkins PN; Stoppini M; Wood SP; Pepys MB; Bellotti V
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1539-44. PubMed ID: 24474780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity.
    Hou X; Richardson SJ; Aguilar MI; Small DH
    Biochemistry; 2005 Aug; 44(34):11618-27. PubMed ID: 16114899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
    Ferreira N; Cardoso I; Domingues MR; Vitorino R; Bastos M; Bai G; Saraiva MJ; Almeida MR
    FEBS Lett; 2009 Nov; 583(22):3569-76. PubMed ID: 19861125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.